Back
ESC Premium Access

Patients eligible for prolonged dual antiplatelet treatment one year after acute coronary syndrome according to the of PRECISE-DAPT score and DAPT score

Session: Poster Session 2 - Coronary artery disease: pharmacotherapy
Topic: Pharmacotherapy
Speaker: Doctor A. Cordero (Elche, ES)
Event: ESC Congress 2018

Congress Presentation

Add to my library

Like

About the speaker

Doctor Alberto Cordero

IMED Elche Hospital, Elche (Spain)
4 presentations
0 follower

9 more presentations in this session

Risk stratification for ischemic and bleeding events in patients using a potent P2Y12 inhibitor

Speaker: Doctor Y. Park (Changwon, KR)

Access
Abstract
Like
Thumbnail

Clinical effects of beta blocker selectivity and dosage regimens in acute myocardial infarction: propensity-score matching analysis

Speaker: Professor U. Kim (Daegu, KR)

Access
Abstract
Slides
Like
Thumbnail

Three for two - a meta-analysis on the optimal antithrombotic regimen in patients undergoing coronary stent implantation with an indication to anticoagulation therapy

Speaker: Doctor F. Fortuni (Perugia, IT)

Access
Abstract
Like
Thumbnail

Single agent clopidogrel is associated with increased all cause mortality compared with aspirin only treatment.

Speaker: Mr V. Parmar (Bushey, GB)

Access
Abstract
Like
Thumbnail

Validity of DAPT score to predict late ischemic and hemorrhagic events in patients with ST-segment-elevation acute coronary syndrome

Speaker: Doctor I. Ferreira Gonzalez (Barcelona, ES)

Access
Abstract
Like
Thumbnail

Access the full session

Poster Session 2 - Coronary artery disease: pharmacotherapy

Speakers: Doctor A. Cordero, Doctor Y. Park, Professor U. Kim, Doctor F. Fortuni, Mr V. Parmar...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources